These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11947965)

  • 1. Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy.
    Miyashita Y; Shirai K; Itoh Y; Sasaki H; Totsuka M; Murano T; Watanabe H
    Diabetes Res Clin Pract; 2002 Jun; 56(3):181-7. PubMed ID: 11947965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.
    Ohira M; Miyashita Y; Ebisuno M; Saiki A; Endo K; Koide N; Oyama T; Murano T; Watanabe H; Shirai K
    Diabetes Res Clin Pract; 2007 Oct; 78(1):34-41. PubMed ID: 17374417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum.
    Shirai K; Itoh Y; Sasaki H; Totsuka M; Murano T; Watanabe H; Miyashita Y
    Diabetes Res Clin Pract; 1999 Oct; 46(1):35-41. PubMed ID: 10580614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity.
    Hanyu O; Miida T; Obayashi K; Ikarashi T; Soda S; Kaneko S; Hirayama S; Suzuki K; Nakamura Y; Yamatani K; Aizawa Y
    Atherosclerosis; 2004 Jun; 174(2):385-90. PubMed ID: 15136071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
    Saiki A; Ohira M; Endo K; Koide N; Oyama T; Murano T; Miyashita Y; Shirai K
    Diabetes Res Clin Pract; 2006 Dec; 74(3):242-8. PubMed ID: 16713009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents.
    Hanyu O; Miida T; Kosuge K; Ito T; Soda S; Hirayama S; Wardaningsih E; Fueki Y; Obayashi K; Aizawa Y
    Clin Chim Acta; 2007 Sep; 384(1-2):118-23. PubMed ID: 17651713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy.
    Miyashita Y; Ebisuno M; Ohhira M; Endoh K; Saiki A; Koide N; Ohtsuka M; Oyama T; Shirai K
    Diabetes Res Clin Pract; 2006 Apr; 72(1):61-7. PubMed ID: 16446009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the serum lipoprotein lipase concentration is useful for studying triglyceride metabolism: Comparison with postheparin plasma.
    Hirano T; Nishioka F; Murakami T
    Metabolism; 2004 Apr; 53(4):526-31. PubMed ID: 15045703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis.
    Hitsumoto T; Ohsawa H; Uchi T; Noike H; Kanai M; Yoshinuma M; Miyashita Y; Watanabe H; Shirai K
    Atherosclerosis; 2000 Dec; 153(2):391-6. PubMed ID: 11164428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the angiotensin II receptor antagonist telmisartan on lipoprotein lipase mass in preheparin serum.
    Hitsumoto T; Takahashi M; Iizuka T; Shirai K
    J Atheroscler Thromb; 2008 Jun; 15(3):138-45. PubMed ID: 18603820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination therapy of benidipine hydrochloride and candesartan cilexetil on serum lipid metabolism and blood pressure in elderly hypertensive patients with type 2 diabetes mellitus.
    Sasaki H; Kanai S; Oyama T; Miyashita Y; Yamamura S; Shirai K
    J Atheroscler Thromb; 2006 Jun; 13(3):149-57. PubMed ID: 16835470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.
    Saiki A; Oyama T; Endo K; Ebisuno M; Ohira M; Koide N; Murano T; Miyashita Y; Shirai K
    Diabetes Res Clin Pract; 2007 Apr; 76(1):93-101. PubMed ID: 16956692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.
    Totsuka M; Miyashita Y; Ito Y; Watanabe H; Murano T; Shirai K
    Atherosclerosis; 2000 Nov; 153(1):175-9. PubMed ID: 11058713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.
    Endo K; Miyashita Y; Saiki A; Oyama T; Koide N; Ozaki H; Otsuka M; Ito Y; Shirai K
    J Atheroscler Thromb; 2004; 11(6):341-7. PubMed ID: 15644588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias.
    Watanabe H; Miyashita Y; Murano T; Hiroh Y; Itoh Y; Shirai K
    Atherosclerosis; 1999 Jul; 145(1):45-50. PubMed ID: 10428294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking.
    Onat A; Hergenç G; Agirbaşli M; Kaya Z; Can G; Unaltuna NE
    Clin Chem Lab Med; 2009; 47(2):208-15. PubMed ID: 19191728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients.
    Ohira M; Yamaguchi T; Saiki A; Nakamura S; Tanaka S; Oka R; Watanabe Y; Sato Y; Oshiro T; Murano T; Tatsuno I
    Obes Facts; 2019; 12(3):357-368. PubMed ID: 31167211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
    Hitsumoto T; Takahashi M; Iizuka T; Shirai K
    J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical determination of the severity of metabolic syndrome: preheparin lipoprotein lipase mass as a new marker of metabolic syndrome.
    Miyashita Y; Shirai K
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):377-81. PubMed ID: 16250868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.